Spirulina Vitamin C D Composition for Multi-Stage Infection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for COVID-19 and other viral infections often fail to effectively address the multiple stages of the infection, including viral replication and inflammatory stages, due to difficulty in determining the exact stage of the disease and the limitations of existing medications in targeting both stages simultaneously without adverse effects.
Innovation Solution
A composition comprising spirulina, vitamin C, and vitamin D, in specific concentrations, which provides anti-viral, anti-inflammatory, and immune modulation properties, effectively treating both the viral and inflammatory stages of COVID-19 and other viral infections, while also preventing blood clotting and crossing the blood-brain barrier to address neurological symptoms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If a single medication is used to treat viral infections, then the treatment is simple and easy to administer, but it cannot effectively address multiple stages of the infection (viral replication and inflammatory stages) simultaneously
Solution Approach 1:
The patent combines multiple active ingredients (vitamin C, vitamin D, spirulina) into a single pharmaceutical composition that can simultaneously address both viral replication and inflammatory stages of infection, resolving the contradiction between ease of administration and multi-stage treatment capability
Solution Approach 2:
The pharmaceutical composition is designed to perform multiple functions: antiviral activity during the replication stage and anti-inflammatory activity during the inflammatory stage, making a single medication versatile enough to handle different stages of the same disease process
2Adaptability or versatility
If multiple medications are used to address different stages of infection, then the treatment can target both viral and inflammatory stages, but the treatment complexity increases and adverse effects may occur
Solution Approach 1:
Multiple medications with different functions (antiviral and anti-inflammatory agents) are merged into a single pharmaceutical composition, maintaining the ability to treat multiple stages while reducing treatment complexity by eliminating the need for separate administration of multiple drugs
Solution Approach 2:
The patent creates a composite pharmaceutical formulation containing multiple active ingredients (vitamin C, vitamin D, spirulina) that work together synergistically to address different pathological processes, achieving multi-stage treatment through a single composite product
3Reliability
If high doses of vitamin C are administered to achieve antiviral and immune benefits, then the therapeutic effect is enhanced, but the risk of kidney stones and hemorrhage increases
Solution Approach 1:
The patent optimizes the dosage parameters of vitamin C to a specific range (200-1000 mg/day) that maintains therapeutic effectiveness while minimizing adverse effects, and balances it with vitamin D and spirulina to achieve synergistic effects at lower individual doses
Solution Approach 2:
Vitamin D and spirulina act as intermediary substances that enhance the overall therapeutic effect, allowing for reduced doses of vitamin C while maintaining or improving therapeutic outcomes and reducing the risk of adverse effects
4Loss of time
If treatment begins at a later stage of the disease, then the patient has progressed further in the infection, but the opportunity to treat at the optimal early stage is lost
Solution Approach 1:
The pharmaceutical composition is designed to be effective across multiple stages of infection (both viral replication and inflammatory stages), so that treatment remains effective regardless of when it is initiated, reducing the negative impact of delayed treatment
Data Source
AI summary
A formulation comprises a combination of spirulina, vitamin C and vitamin D. In some versions (i) the spirulina comprises between 0.25X and 4X, wherein X is 452 milligrams, (ii) the vitamin C comprises between 0.25Y and 4Y, wherein Y is 298 milligrams, and (iii) the vitamin D comprises between 0.25Z and 4Z, wherein Z is 298 International Units (IU). A method of treating a Covid-19 coronavirus infection in a person, by administering to the person a daily dosage of a medicament that comprises spirulina, vitamin C and vitamin D, and a method of treating a pathogenic inflammation in a person by administering to the person a daily dosage of a medicament that comprises spirulina, vitamin C and vitamin D, are described. A method of treating asthma in a person by administering to the person a daily dosage of a medicament that comprises spirulina, vitamin C; and vitamin D is described.